BiotechTube
Agility Life Sciences

Agility Life Sciences

Cambridge, United Kingdom· Est.
agilitylifesciences.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

Agility Life Sciences is an award-winning formulation development CDMO founded in 2010 and headquartered in Cambridge, UK. The company provides fee-for-service formulation development, turning 'badly behaved' molecules into optimized drug products for preclinical and clinical studies. A key strategic move is its 2025 Integrated CMC Partnership with Sai Life Sciences and Centrix Pharma Solutions, offering clients an end-to-end service from API development to clinical trial manufacturing. As a private, service-based company, Agility's business model centers on generating revenue through client projects while all developed IP remains with the client.

Drug DeliveryMedical Devices

Technology Platform

Futureproof Formulations Fast™ - A holistic formulation development approach that integrates molecule properties, client end-goals, study requirements, and species considerations to create scalable, optimized drug products for poorly soluble, permeable, or unstable molecules.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The Integrated CMC Partnership offers a significant growth opportunity by providing end-to-end services, attracting larger client projects, and creating a more predictable revenue stream.
The persistent industry challenge of poor drug solubility and bioavailability ensures continued demand for advanced formulation expertise, particularly for novel modalities.

Risk Factors

Revenue is highly susceptible to fluctuations in biotech funding cycles.
The company faces intense competition from both large global CDMOs and specialized formulation boutiques.
The success of the new strategic partnership is critical and depends on effective integration and collaboration between three independent entities.

Competitive Landscape

Agility competes in the specialized formulation CDMO space against companies like Catalent, Lonza (through its Capsugel division), and numerous smaller niche players. Its differentiation is its focused 'problem molecule' philosophy, multi-route expertise, and the new integrated partnership model, which offers a seamless CMC pathway few boutique CDMOs can match.

More companies in Drug Delivery & Formulation →More companies in United Kingdom →